A patient with lung adenocarcinoma and with a homozygous stop-gain mutation in BARD1 (G320*) and a duplication event in RBBP8 (e3–4 duplication) was also classified as HRD by HRDetect but not by CHORD. The gene discussed is BARD1; the disease is lung adenocarcinoma.